Author:
Hayakawa Kayoko,Marchaim Dror,Martin Emily T.,Tiwari Namita,Yousuf Adnan,Sunkara Bharath,Pulluru Harish,Kotra Harikrishna,Hasan Asma,Bheemreddy Suchitha,Sheth Puja,Lee Dae-Won,Kamatam Srinivasa,Bathina Pradeep,Nanjireddy Priyanka,Chalana Indu K.,Patel Satyam,Kumar Sarwan,Vahia Amit,Ku Kimberly,Yee Victoria,Swan Jessie,Pogue Jason M.,Lephart Paul R.,Rybak Michael J.,Kaye Keith S.
Abstract
ABSTRACTIn published studies, cohorts of patients with bacteremia due to vancomycin-resistantEnterococcus(VRE) have predominantly been infected withEnterococcus faecium. Little is known about the epidemiology and outcomes associated with bacteremia due to VREnterococcus faecalis. A retrospective study of isolates obtained from January 2008 to October 2010 was conducted at Detroit Medical Center (DMC). Unique patients with blood cultures positive for VRE were reviewed. Outcomes were analyzed using logistic regression. During the study period, 105 cases of bacteremia due to VRE. faecalisand 197 cases of bacteremia due to VRE. faeciumwere identified. The mean age in the study cohort was 61.5 ± 15 years; 162 subjects (53.6%) were male. After controlling for a propensity score, bacteremia due to VRE. faecaliswas associated with >2-fold-lower in-hospital mortality than bacteremia due to VRE. faecium. Interestingly, bacteremia due to VRE. faecaliswas associated with longer hospital stay after VRE isolation, although total length of stay was similar for groups with VRE. faecalisand VRE. faecium. Bacteremia due to VRE. faecaliswas associated with a >2-fold-lower risk for mortality than bacteremia due to VRE. faecium, possibly due to the availability of β-lactam therapeutics for treatment of VRE. faecalis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference28 articles.
1. Management of multidrug-resistant enterococcal infections;Arias;Clin. Microbiol. Infect.,2010
2. Validation of a prognostic score in critically ill patients undergoing transport;Bion;Br. Med. J. (Clin. Res. Ed.),1985
3. Health and economic outcomes of vancomycin-resistant enterococci;Carmeli;Arch. Intern. Med.,2002
4. Centers for Disease Control and Prevention. 2011. Central line-associated bloodstream infection (CLABSI) event. http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Centers for Disease Control and Prevention, Atlanta, GA.
5. Vancomycin-resistant enterococci;Cetinkaya;Clin. Microbiol. Rev.,2000
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献